First-of-its-kind narcolepsy drug opens door to new therapies for the brain
Nature, Published online: 17 August 2026; doi:10.1038/d41586-026-02552-y The drug, called Orzeyful, takes aim at the root cause of the sleep disorder rather than at its symptoms.
On a recent occasion, the U.S. Food and Drug Administration granted authorization to the inaugural medicine explicitly crafted to address the underlying cause of narcolepsy, a condition impacting numerous individuals by inducing overwhelming daytime drowsiness and nighttime wakefulness. Local taxes may influence the final cost, determined at the time of purchase.
Written by urgent.news from Nature's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
